Next Generation Sequencing Analysis of Patients with Spontaneous Dissection of Cervical Arteries

NCT06862063 · tracked via the Priya Life Science Italy tracker

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase

Not applicable

Started

2024-12-01

Last updated

2025-03-06

Condition(s) studied

Dissection Carotid ArteryDissection ArterialDissecting Aneurysm

Investigational drug(s) / intervention(s)

Genetic testing

Genetic testing: Each eligible patient will undergo a blood sample to perform a genetic analysis through Next Generation Sequencing (NGS) technique in order to analyze a high number of genes involved in the structure/function of connective tissue

Study summary

The goal of this observational study is to analyze the existence of a genetic predisposition in patients with spontaneous dissections of the cervical arteries (SCeAD).

The main questions it aims to answer are:

1. Which is the prevalence of pathogenic variants in genes coding for proteins involved in the structure or function of the connective tissue in adult patients with spontaneous dissections of the cervical arteries?
2. Which are the clinical characteristics of each single genetic variant identified?
3. Which are the clinical, radiological, laboratory variables associated with the finding of a pathogenic variant?
4. Are there differences between patients with SCeAD who have a pathogenic variant in a gene coding for proteins involved in the structure or function of the connective tissue and those who not?
5. There are differences in the risk of SCeAD recurrence between patients with SCeAD who have a pathogenic variant in a gene coding for proteins involved in the structure or function of the connective tissue and those who not?
6. There are differences in the risk of SCeAD recurrence based on the specific typology of genetic variant found?

Participants will be asked to undergo:

* a whole-CT total-body with contrast;
* a dysmorphological visit;
* a blood sampling for genetic testing;
* a neurological visit;
* Some follow-up visits.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Adult age (≥18 years); * Presence of a dissection of one or more cervical arteries (carotid or vertebrobasilar district), defined as the finding, on an appropriate radiological examination (CT and/or MRI of the neck and brain district with/without contrast medium and/or digital subtraction angiography and/or echocolordoppler of the epiaortic vessels) of "intramural hematoma, pseudoaneurysmal dilation, intimal flap, double lumen, long tapering stenosis or occlusion ≥2 cm above the carotid bifurcation with finding of an aneurysmal dilation or a long tapering stenosis after recanalization of the vessel"; * At least one or more of the following criteria: * Radiological evidence on CT and/or MRI with/without contrast and/or digital subtraction angiography and/or color Doppler ultrasound of vessel wall anomalies (such as aneurysms, dissections, tortuosity, ectasia or vascular stenosis) in one or more vascular districts in addition to that of the known dissection; * Family history of: * vessel dissections and/or sudden death and/or cerebrovascular or cardiovascular diseases at a young age; * spontaneous perforation of internal organs and/or dehiscence and/or laxity of connective tissue (spontaneous prolapses); * dysmorphological abnormalities at the clinical examination (including Beighton score ≥5 or Marfan score ≥7), laboratory and/or radiological findings suggestive of connective tissue disease or other genetic condition known to be associated with the development of aneurysms or alterations of the vessel wall; * Written informed consent Exclusion Criteria: * Recent history of trauma clearly related in type, location and dynamics to the development of dissection; * Iatrogenic dissection following endovascular procedure; * Exclusively intracranial dissection; * Fibromuscular dysplasia.

Primary outcome measure(s)

Definition of the percentage prevalence (n - %) of pathogenic variants in patients with Spontaneous Cervical Artery Dissection (SCeAD) — Through study completion, an average of 2 years and six months
To define the percentage prevalence (n - %) of pathogenic variants of genes encoding proteins involved in the structure/function of connective tissue in patients with spontaneous dissection of the cervical arteries

Trial sites (1)

Facility	City	Region	Status
Fondazione Policlinico Universitario A. Gemelli IRCCS	Rome	Lazio	Recruiting

More Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials in Italy

The Management of Asymptomatic Carotid Stenosis Recruiting

Modular Neurological Examination for Early Risk Detection Active, not recruiting

Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab. Recruiting

BRCA Mutation Carriers' Platform a Multicenter Study Recruiting

Superior Cervical Ganglion in Parkinson's Disease Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06862063 on ClinicalTrials.gov ↗ ← All trials in Italy